TrialDiabetes care2022

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.

Peter Rossing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.